Cargando…

Cytokines associated with insulin resistance in critically ill patients

Detalles Bibliográficos
Autores principales:	Omar, S, Wilgen, U, Crowther, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095174/ http://dx.doi.org/10.1186/cc5280

Ejemplares similares

Relation of Resting Membrane Polarization and Insulin Resistance in Critically Ill Patients
por: Koch, S, et al.
Publicado: (2015)

Urinary and plasma cytokines in the critically ill
por: Adam, Z, et al.
Publicado: (2006)

Endogenous insulin secretion in critically ill patients
por: Pretty, C, et al.
Publicado: (2012)

Errors in preparation of insulin infusions for critically ill patients
por: Pierson, R, et al.
Publicado: (2011)

Glargine insulin: an alternative to regular insulin for glycemic control in critically ill patients
por: Bhattacharyya, M, et al.
Publicado: (2007)

Troponin incidence, prevalence and prognosis among critically ill patients
por: Lim, W, et al.
Publicado: (2005)

Insulin signaling in critical illness: intensive versus conventional insulin therapy
por: Langouche, L, et al.
Publicado: (2005)

The reliability of electrocardiogram interpretation in critically ill patients
por: Lim, W, et al.
Publicado: (2005)

Computer-advised insulin infusion in critically ill patients – a randomized controlled trial
por: Cordingley, J, et al.
Publicado: (2007)

Mechanisms of kidney protection by intensive insulin therapy during critical illness
por: Vanhorebeek, I, et al.
Publicado: (2008)

Protection of mitochondria by intensive insulin therapy in critical illness: blood glucose control or insulin?
por: Vanhorebeek, I, et al.
Publicado: (2006)

Effect of intensive insulin therapy on coagulation and fibrinolysis of respiratory critically ill patients
por: Langouche, L, et al.
Publicado: (2007)

Results of an intensive insulin infusion protocol in diabetic and nondiabetic critically ill patients
por: Gomes, PN, et al.
Publicado: (2005)

Cortisol metabolism in critical illness: effects of intensive insulin therapy
por: Vanhorebeek, I, et al.
Publicado: (2005)

Time-course evaluation of blood glucose changes in response to insulin delivery in critically ill patients
por: Bass, F, et al.
Publicado: (2014)

Variability of insulin sensitivity during the first 4 days of critical illness
por: Pretty, C, et al.
Publicado: (2012)

Endogenous insulin secretion and suppression during and after sepsis in critically ill patients: implications for tight glycemic control protocols
por: Pretty, CG, et al.
Publicado: (2011)

Comparison of a bronchoscopic microsample probe with bronchoalveolar lavage to measure cytokine levels in critically ill patients
por: Grover, V, et al.
Publicado: (2012)

Severe hypoglycaemia during intensive insulin therapy: a rare event in critically ill patients
por: Kaukonen, M, et al.
Publicado: (2007)

Hypothalamic-pituitary-adrenal axis in mechanically ventilated critically ill patients: incidence of hyporesponsiveness to stimulation and relationship to cytokine levels
por: Dimopoulou, I, et al.
Publicado: (2006)

Implementing intensive insulin therapy in daily practice reduces the incidence of critical illness polyneuropathy and/or myopathy
por: Berends, N, et al.
Publicado: (2008)

Intensive insulin therapy versus glycemic control in critically ill patients: a prospective controlled trial
por: Azevedo, JR, et al.
Publicado: (2007)

Sepsis-associated brain dysfunction in critically ill patients
por: Tomasi, Cristiane Damiani, et al.
Publicado: (2013)

Effects of hyperglycemia and intensive insulin therapy on neurons and glial cells during critical illness
por: Sonneville, R, et al.
Publicado: (2011)

Organ dysfunction in critical illness: impact of maintaining normoglycemia and glycemia-independent insulin actions
por: Ellger, B, et al.
Publicado: (2006)

Multiscale modeling of acute insulin resistance in critical care
por: Pritchard-Bell, A, et al.
Publicado: (2013)

Neutrophil-to-lymphocyte ratio is associated with mortality in critically-ill cirrhotic patients
por: Moreau, N, et al.
Publicado: (2015)

Effect of glucose–insulin–potassium infusion on mortality in critically ill patients: a systematic review and meta-analysis
por: Puskarich, M, et al.
Publicado: (2009)

Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015)

Concentration of major vitamins in critically ill patients
por: Hayami, H, et al.
Publicado: (2012)

Strict blood glucose control with insulin improves hepatic mitochondrial ultrastructure and function in critical illness
por: Vanhorebeek, I, et al.
Publicado: (2004)

Hypoglycaemia is associated with a higher mortality in critically ill patients
por: Pereira, A Jose, et al.
Publicado: (2009)

Acute transfusion reactions in critically ill pediatric patients
por: Ozata, N, et al.
Publicado: (2008)

Validation of non-invasive hemodynamic monitoring with Nexfin in critically ill patients
por: Van de Vijver, K, et al.
Publicado: (2011)

Magnesium at admission: is it an outcome marker in the critically ill patient?
por: Passakiotou, M, et al.
Publicado: (2005)

Critically ill patients with Takotsubo cardiomyopathy
por: Oishi, JO, et al.
Publicado: (2007)

Nutritional support in critically ill patients
por: Thanthulage, S, et al.
Publicado: (2007)

Which variables affect strict glycaemic control with intensive insulin therapy in postoperative/post-traumatic critically ill patients?
por: Weiss, M, et al.
Publicado: (2009)

Biomarkers of delirium in critically ill patients
por: Van den Boogaard, M, et al.
Publicado: (2011)

Endogenous melatonin in critically ill patients
por: Salice, VS, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mm5qogp5q28764i7rm6l3kk99u